Axon guidance gene-targeted siRNA delivery system improves neural stem cell transplantation therapy after spinal cord injury

Abstract Background Neural stem cells (NSCs) derived from the embryonic spinal cord are excellent candidates for the cellular regeneration of lost neural cells after spinal cord injury (SCI). Semaphorin 3 A (Sema3A) is well known as being implicated in the major axon guidance of the growth cone as a...

Full description

Bibliographic Details
Main Authors: Seong Jun Kim, Wan-Kyu Ko, Gong Ho Han, Daye Lee, Min Jai Cho, Seung Hun Sheen, Seil Sohn
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2023-10-01
Series:Biomaterials Research
Subjects:
Online Access:https://doi.org/10.1186/s40824-023-00434-2
_version_ 1797280061630447616
author Seong Jun Kim
Wan-Kyu Ko
Gong Ho Han
Daye Lee
Min Jai Cho
Seung Hun Sheen
Seil Sohn
author_facet Seong Jun Kim
Wan-Kyu Ko
Gong Ho Han
Daye Lee
Min Jai Cho
Seung Hun Sheen
Seil Sohn
author_sort Seong Jun Kim
collection DOAJ
description Abstract Background Neural stem cells (NSCs) derived from the embryonic spinal cord are excellent candidates for the cellular regeneration of lost neural cells after spinal cord injury (SCI). Semaphorin 3 A (Sema3A) is well known as being implicated in the major axon guidance of the growth cone as a repulsive function during the development of the central nervous system, yet its function in NSC transplantation therapy for SCI has not been investigated. Here, we report for the first time that embryonic spinal cord-derived NSCs significantly express Sema3A in the SCI environment, potentially facilitating inhibition of cell proliferation after transplantation. Methods siRNA-Sema3A was conjugated with poly-l-lysin-coated gold nanoparticles (AuNPs) through a charge interaction process. NSCs were isolated from embryonic spinal cords of rats. Then, the cells were embedded into a dual-degradable hydrogel with the siRNA- Sema3A loaded-AuNPs and transplanted after complete SCI in rats. Results The knockdown of Sema3A by delivering siRNA nanoparticles via dual-degradable hydrogels led to a significant increase in cell survival and neuronal differentiation of the transplanted NSCs after SCI. Of note, the knockdown of Sema3A increased the synaptic connectivity of transplanted NSC in the injured spinal cord. Moreover, extracellular matrix molecule and functional recovery were significantly improved in Sema3A-inhibited rats compared to those in rats with only NSCs transplanted. Conclusions These findings demonstrate the important role of Sema3A in NSC transplantation therapy, which may be considered as a future cell transplantation therapy for SCI cases. Graphical Abstract
first_indexed 2024-03-07T16:34:48Z
format Article
id doaj.art-c2dee162e73f4d8d9e6a74ceac89b1dc
institution Directory Open Access Journal
issn 2055-7124
language English
last_indexed 2024-03-07T16:34:48Z
publishDate 2023-10-01
publisher American Association for the Advancement of Science (AAAS)
record_format Article
series Biomaterials Research
spelling doaj.art-c2dee162e73f4d8d9e6a74ceac89b1dc2024-03-03T09:49:17ZengAmerican Association for the Advancement of Science (AAAS)Biomaterials Research2055-71242023-10-0127111510.1186/s40824-023-00434-2Axon guidance gene-targeted siRNA delivery system improves neural stem cell transplantation therapy after spinal cord injurySeong Jun Kim0Wan-Kyu Ko1Gong Ho Han2Daye Lee3Min Jai Cho4Seung Hun Sheen5Seil Sohn6Department of Neurosurgery, CHA Bundang Medical Center, CHA UniversityDepartment of Neurosurgery, CHA Bundang Medical Center, CHA UniversityDepartment of Neurosurgery, CHA Bundang Medical Center, CHA UniversityDepartment of Neurosurgery, CHA Bundang Medical Center, CHA UniversityDepartment of Neurosurgery, Chungbuk National UniversityDepartment of Neurosurgery, CHA Bundang Medical Center, CHA UniversityDepartment of Neurosurgery, CHA Bundang Medical Center, CHA UniversityAbstract Background Neural stem cells (NSCs) derived from the embryonic spinal cord are excellent candidates for the cellular regeneration of lost neural cells after spinal cord injury (SCI). Semaphorin 3 A (Sema3A) is well known as being implicated in the major axon guidance of the growth cone as a repulsive function during the development of the central nervous system, yet its function in NSC transplantation therapy for SCI has not been investigated. Here, we report for the first time that embryonic spinal cord-derived NSCs significantly express Sema3A in the SCI environment, potentially facilitating inhibition of cell proliferation after transplantation. Methods siRNA-Sema3A was conjugated with poly-l-lysin-coated gold nanoparticles (AuNPs) through a charge interaction process. NSCs were isolated from embryonic spinal cords of rats. Then, the cells were embedded into a dual-degradable hydrogel with the siRNA- Sema3A loaded-AuNPs and transplanted after complete SCI in rats. Results The knockdown of Sema3A by delivering siRNA nanoparticles via dual-degradable hydrogels led to a significant increase in cell survival and neuronal differentiation of the transplanted NSCs after SCI. Of note, the knockdown of Sema3A increased the synaptic connectivity of transplanted NSC in the injured spinal cord. Moreover, extracellular matrix molecule and functional recovery were significantly improved in Sema3A-inhibited rats compared to those in rats with only NSCs transplanted. Conclusions These findings demonstrate the important role of Sema3A in NSC transplantation therapy, which may be considered as a future cell transplantation therapy for SCI cases. Graphical Abstracthttps://doi.org/10.1186/s40824-023-00434-2Spinal cord injuriesNeural stem cellsSemaphorin-3ASmall interfering RNAAxon guidance
spellingShingle Seong Jun Kim
Wan-Kyu Ko
Gong Ho Han
Daye Lee
Min Jai Cho
Seung Hun Sheen
Seil Sohn
Axon guidance gene-targeted siRNA delivery system improves neural stem cell transplantation therapy after spinal cord injury
Biomaterials Research
Spinal cord injuries
Neural stem cells
Semaphorin-3A
Small interfering RNA
Axon guidance
title Axon guidance gene-targeted siRNA delivery system improves neural stem cell transplantation therapy after spinal cord injury
title_full Axon guidance gene-targeted siRNA delivery system improves neural stem cell transplantation therapy after spinal cord injury
title_fullStr Axon guidance gene-targeted siRNA delivery system improves neural stem cell transplantation therapy after spinal cord injury
title_full_unstemmed Axon guidance gene-targeted siRNA delivery system improves neural stem cell transplantation therapy after spinal cord injury
title_short Axon guidance gene-targeted siRNA delivery system improves neural stem cell transplantation therapy after spinal cord injury
title_sort axon guidance gene targeted sirna delivery system improves neural stem cell transplantation therapy after spinal cord injury
topic Spinal cord injuries
Neural stem cells
Semaphorin-3A
Small interfering RNA
Axon guidance
url https://doi.org/10.1186/s40824-023-00434-2
work_keys_str_mv AT seongjunkim axonguidancegenetargetedsirnadeliverysystemimprovesneuralstemcelltransplantationtherapyafterspinalcordinjury
AT wankyuko axonguidancegenetargetedsirnadeliverysystemimprovesneuralstemcelltransplantationtherapyafterspinalcordinjury
AT gonghohan axonguidancegenetargetedsirnadeliverysystemimprovesneuralstemcelltransplantationtherapyafterspinalcordinjury
AT dayelee axonguidancegenetargetedsirnadeliverysystemimprovesneuralstemcelltransplantationtherapyafterspinalcordinjury
AT minjaicho axonguidancegenetargetedsirnadeliverysystemimprovesneuralstemcelltransplantationtherapyafterspinalcordinjury
AT seunghunsheen axonguidancegenetargetedsirnadeliverysystemimprovesneuralstemcelltransplantationtherapyafterspinalcordinjury
AT seilsohn axonguidancegenetargetedsirnadeliverysystemimprovesneuralstemcelltransplantationtherapyafterspinalcordinjury